Self-monitoring of blood glucose improved glycemic control and the 10-year coronary heart disease risk profile of female type 2 diabetes patients in Trinidad and Tobago

Nigerian Journal of Clinical Practice

Volumn 14, Issue 1, 2011, Pages 1-5

  Ezenwaka, C E ^a   Dimgba, A ^b   Okali, F ^b   Skinner, T ^a   Extavour, R ^a   Rodriguez, M ^a   Jones LeCointe, A ^a  

^a UNIVERSITY OF THE WEST INDIES   (Trinidad and Tobago)

^b Tobago Regional Health Authority   (Trinidad and Tobago)

Author keywords

Afro caribbean; Coronary heart disease; Glycemic control; Type 2 diabetes

Indexed keywords

ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN;

ARTICLE; BLOOD; BLOOD GLUCOSE MONITORING; BLOOD PRESSURE; CASE CONTROL STUDY; CORONARY ARTERY DISEASE; ETHNOLOGY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LIPID METABOLISM; METABOLISM; MIDDLE AGED; NEGRO; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSPECTIVE STUDY; RISK FACTOR; SOCIOECONOMICS; TIME; TRINIDAD AND TOBAGO;

AFRICAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; BLOOD PRESSURE; CASE-CONTROL STUDIES; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; LIPID METABOLISM; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; SOCIOECONOMIC FACTORS; TIME FACTORS; TRINIDAD AND TOBAGO;

EID: 79955396021     PISSN: 11193077     EISSN: None     Source Type: Journal    
DOI: 10.4103/1119-3077.79230     Document Type: Article

References (33)

1. Kannel WB. Metabolic risk factors for coronary heart disease in women: perspective from the Framingham Study.Am Heart J 1987; 1 14:413-9. (Pubitemid 17131737)
2. Barrett-Connor EL, Cohn BA, Wingard DL, Edelstein SL Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men?The Rancho Bernardo Study.JAMA 1991;265:627-31.
3. Sowers JR. Diabetes mellitus and cardiovascular disease in women Arch Intern Med 1998;158:617-21. (Pubitemid 28144819)
4. Mercuro G, Zoncu S, Dragoni F. Gender differences in cardiovascular risk factors. Ital Heart J 2003:4:363-6. (Pubitemid 38401484)
5. ,Willett WC, Manson JE, Rosner B, Speizer FE, et al. Postmenopausal estrogen therapy and cardiovascular disease.Ten-year followup from the nurses' health study. N Engl J Med 1991:325:756-62.
6. , et al. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med 1996;335:453-61.
7. Forssas EH,Keskimäki IT, Reunanen AR, Koskinen SV.Coronary heart disease among diabetic and nondiabetic people - socioeconomic differences in incidence, prognosis and mortality.J Diabetes Complications 2008;22:10-7.
8. Kaseta JR, Skafar DF, Ram JL,Jacober SJ, Sowers JR. Cardiovascular disease in the diabetic woman.J Clin Endocrinol Metab 1999;84:1835-8. (Pubitemid 30646994)
9. Ezenwaka CE, Akanji AO, Akanji BO, Unwin NC, Adejuwon CA. The prevalence of insulin resistance and other cardiovascular disease risk factors in healthy elderly southwestern Nigerians.Atherosclerosis 1997; 128:201-11. (Pubitemid 27092155)
10. Nagpal J, BhartiaA.Cardiovascular risk profile of subjects with known diabetes from the middle- and high-income group population of Delhi: the DEDICOM survey. Diabet Med 2008;25:27-36.
11. Ezenwaka CE,Offiah NV. Cardiovascular risk in obese and nonobese patients with type 2 diabetes in the West Indies.J Biomed Sci. 2001;8:314-20.
12. Ezenwaka CE, Davis G. Increased risk of cardiovascular disease in newly diagnosed type 2 diabetic patients in a primary health care center in Trinidad. Diabetes Res Clin Pract.2000;50:137-45.
13. Ezenwaka CE, Offiah NV. Differences in cardiovascular disease risk factors in elderly and younger patients with type 2 diabetes in theWest Indies.Singapore Med J 2002;43:497-503.
14. Ezenwaka CE, Nwagbara E, Seales D, Okali F, Hussaini S, Raja B, et al. A comparative study of the prevalence of the metabolic syndrome and its components in type 2 diabetic patients in two Caribbean islands using the new International Diabetes Federation definition. Arch Physiol Biochem. 2007;113:202-10.
15. The Government of the Republic of Trinidad and Tobago. Ministry of Planning and Development, Central Statistical Office, Population, Social and Vital Statistics, Five Leading Causes of Death 1999, official website: http://www.cso.gov.tt/.
16. Ezenwaka CE, Nwagbara E, Seales D, Okali F, Hussaini S, Raja B, et al. Prediction of 10-year coronary heart disease risk in Caribbean type 2 diabetic patients using the UKPDS risk engine. Int J Cardiol 2009; 132:348-53.
17. Anderson KM,Odell PM,Wilson PW Kannel WB. Cardiovascular disease risk profiles. Am Heart J 1991; 121:293-8.
18. Stevens RJ, Kothari V, Adler Al, Stratton IM. United Kingdom Prospective Diabetes Study Group. The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56). Clin Sci (Lond) 2001;101:671-9.
19. Song SH, Brown PM. Coronary heart disease risk assessment in diabetes mellitus: comparison of UKPDS risk engine with Framingham risk assessment function and its clinical implications. Diabet Med 2004;21:238-45.
20. Goldstein DE, Little RR, Lorenz RA, Malone Jl, Nathan D, Peterson CM, et al. Tests of glycemia in diabetes. Diabetes Care 2004;27:1761-73.
21. American Diabetes Association: Standard of medical care of diabetes. Diabetes Care 2007; (Suppl. 1):S4-S41.
22. Diabetes Control and Complications Trial Research Group. The effect of intensive diabetes treatment on the development and progression of longterm complications in insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. N Engl J Med 1993;329:978-86.
23. UK Prospective Diabetes Study Group. Intensive blood glucose control with sulphonylurea or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.
24. Stratton IM, Adler Al, Neil HA, Matthews DR, Manley SE, Cull CA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000;321:405-12.
25. Erasmus RT, Blanco Blanco E, Okesina AB, Gqweta Z, Matsha T. Assessment of glycaemic control in stable type 2 black South African diabetics attending a peri-urban clinic. Postgrad Med J 1999;75:603-6. (Pubitemid 29452589)
26. Erasmus RT, SinhaAK.Assessment of long-term glycaemic control in diabetic patients attending Port Moresby General Hospital. P N G Med J 1995;38:16-9.
27. Ezenwaka CE. Metabolic control of type-2 diabetic patients commonly treated with sulphonylureas in a developing country. East Afr Med J 2003;80:175-80. (Pubitemid 41289252)
28. Ford ES, Li C, Little RR, Mokdad AH.Trends in AIC concentrations among U.S. adults with diagnosed diabetes from 1999 to 2004. Diabetes Care 2008;31:102-4.
29. 1c levels between African-American and non-Hispanic white adults with diabetes: a meta-analysis. Diabetes Care 2006;29:2130-6.
30. National Institute for Clinical Excellence. Management of type 2 diabetes: management of blood pressure and blood lipids. London National Institute for Clinical Excellence; 2002.
31. Brackenridge BP. Diabetes education: a global perspective. Diabetes spectrum 1999; 12:132.
32. Ezenwaka CE, Offiah NV. Patients' health education and diabetes control in a developing country.Acta Diabetol 2003;40:173-5.
33. Davidson MB.Counterpoint:Self-monitoring of blood glucose in type 2 diabetic patients not receiving insulin:a waste of money. Diabetes Care 2005;28:1531-3. (Pubitemid 40756733)